Patients with chronic hepatitis B virus (HBV) infection hasv historica
lly incurred high rates of allograft reinfection from extrahepatic res
ervoirs of HBV, with worse long term outcome compared with that of tra
nsplant recipients without HBV infection. As a result, chronic HBV inf
ection has been considered a contraindication for transplantation. Pro
phylaxis against HBV recurrence, in the form of passive immunization w
ith high dose hepatitis B hyperimmunoglobulin and the antiviral agent
lamivudine, has recently been demonstrated to decrease the risk of rei
nfection. With appropriate prophylaxis, liver transplantation can be a
viable proposition for patients with HBV infection. Past experience a
nd current status of HBV infection and transplantation are reviewed, w
ith emphasis on the issues surrounding prophylaxis.